about
Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia.Fast exocytosis mediated by T- and L-type channels in chromaffin cells: distinct voltage-dependence but similar Ca2+ -dependence.L-type calcium channels in adrenal chromaffin cells: role in pace-making and secretion.VEGF blockade enhances the antitumor effect of BRAFV600E inhibition.CaV1.3 as pacemaker channels in adrenal chromaffin cells: specific role on exo- and endocytosis?Bioengineered tumoral microtissues recapitulate desmoplastic reaction of pancreatic cancer.L-type channel inhibition by CB1 cannabinoid receptors is mediated by PTX-sensitive G proteins and cAMP/PKA in GT1-7 hypothalamic neurons.Calcium-dependent inhibition of T-type calcium channels by TRPV1 activation in rat sensory neurons.Multipotent mesenchymal stem cells from amniotic fluid originate neural precursors with functional voltage-gated sodium channels.PDE type-4 inhibition increases L-type Ca(2+) currents, action potential firing, and quantal size of exocytosis in mouse chromaffin cells.Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies.PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations.Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment.SPAD aptasensor for the detection of circulating protein biomarkers.Chronic hypoxia up-regulates alpha1H T-type channels and low-threshold catecholamine secretion in rat chromaffin cellsTFEB controls vascular development by regulating the proliferation of endothelial cells
P50
Q35751013-E8A680D6-1EE3-44F2-8F41-F7ACEEBCA24CQ36752731-53422C40-9C25-423D-88A9-CAB63C49F0A0Q36846516-F5623D98-FBCC-44F2-94FD-4DDE71DEC925Q37618011-18377665-1CEC-4B17-B8BF-AE11FDF6AAA2Q37810430-6BB00910-1546-4FC2-916E-685A84F24DB5Q38787361-ED3116CA-BA62-4A8A-8318-71FADD5E2D43Q39789306-DEF1FDEA-8FDC-4BFC-9CED-2229C6B1529BQ43849037-68AA3A73-B0A2-4904-B46F-1ECCB10BC268Q44280495-8F39DCD9-8F83-4D9C-A6E1-B48028909B4EQ46380083-D00C9FB7-DC84-49B3-A98D-6EA34DE44D24Q47134647-AB0B67EB-7509-42F8-B5CD-52EA99E82D66Q48204602-30B0AF0C-363B-4E49-81B1-8E4ECAC2FCE9Q52688134-EB0C5788-B6A3-4E5D-B408-C864DC09BE30Q53325484-12571914-890F-4182-8A71-6F18390366B9Q60519767-F232AB41-22CD-4620-831D-9326A91588C2Q61812478-1CF632BF-61C8-44FD-AF3E-73FB0DB1490C
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Valentina Comunanza
@ast
Valentina Comunanza
@en
Valentina Comunanza
@es
Valentina Comunanza
@nl
Valentina Comunanza
@sl
type
label
Valentina Comunanza
@ast
Valentina Comunanza
@en
Valentina Comunanza
@es
Valentina Comunanza
@nl
Valentina Comunanza
@sl
prefLabel
Valentina Comunanza
@ast
Valentina Comunanza
@en
Valentina Comunanza
@es
Valentina Comunanza
@nl
Valentina Comunanza
@sl
P106
P21
P31
P496
0000-0002-0695-6420